جست‌وجوی استاد و پژوهشگر

• Opioid Receptor Pharmacology
• Pain Neurobiology
• Addiction Neuroscience
• +۳ مورد دیگر

Nicolas Massaly is an Assistant Professor in the Department of Anesthesiology , David Geffen School of Medicine at University of California, Los Angeles (UCLA) . His research focuses on the intersection of pain neurobiology, opioid pharmacology, and addiction neuroscience , with particular emphasis on opioid receptor dynamics, neural circuitry in addiction, and non-addictive pain therapies . Key research areas: Opioid receptor antagonism, pain-addiction comorbidity, neuroimmune interactions, and biomedical device development for overdose prevention Academic contributions: 15+ peer-reviewed publications (2010-2025) in journals like Nature Neuroscience , Neuron , and Science , covering opioid system dysregulation, pain-induced behavioral adaptations, and receptor-specific pharmacology Collaborative networks: Active in opioid research with co-authors including Catherine Cahill (UCLA) and J. Anthony Morón (Washington University) Current affiliations: Maintains research presence in UCLA's Department of Anesthesiology with focus on translational studies from rodent models to clinical applications His work has been cited in 100+ publications and highlighted across academic networks, news outlets, and social media , indicating significant impact in addressing the opioid epidemic through neuropharmacological and technological innovations .

Ben Rossمشاهده پروفایل

مدرس ارشد

• Medicinal Chemistry
• Computer-Aided Drug Design
• Virtual Screening
• +۱۱ مورد دیگر

Dr. Ben Ross is a Senior Lecturer at the School of Pharmacy and Pharmaceutical Sciences , Faculty of Health, Medicine and Behavioural Sciences , University of Queensland. With a background in medicinal chemistry and synthetic chemistry, his research focuses on computer-aided drug design for cancer , viral infections , and neurodegenerative diseases like Alzheimer’s. His team employs biochemical , biophysical , and cell-based assays , alongside animal models , to evaluate novel drug candidates, emphasizing ADMET properties for clinical translation. Education : BSc (First-Class Honours), University of Queensland (1999) PhD in Medicinal Chemistry, University of Queensland (2004) Research Themes include virtual screening, enzyme inhibition, ion channel modulation, and nanoparticle-based drug delivery systems . His work spans computer-aided design of acetylcholinesterase inhibitors , Orai1 calcium channel modulators , and antiviral nanoparticles . Recent projects highlight 3D-printed tablets for personalized prednisone dosing and pH-responsive nanocarriers for colon-targeted therapy. Publications demonstrate expertise in medicinal chemistry (75 total), with high-impact work in Journal of Medicinal Chemistry , ACS Applied Materials & Interfaces , and Nanoscale . Themes include virtual screening , nanoparticle drug delivery , and multi-target inhibitors for neurodegeneration and cancer. Collaborations with local and international researchers enhance translational impact. Supervision & Funding : Actively mentors PhD students in oral drug delivery , Alzheimer’s therapies , and 3D printing , with support from UQ Scholarships , NHMRC , and international programs (MOHE, Saudi Arabia, CSC). Leads the RossChemLab , emphasizing drug-likeness and collaborative discovery .

Kajsa M Paulssonمشاهده پروفایل

پژوهشگر

• Immunology
• Antigen Presentation
• Structural Biology
• +۵ مورد دیگر

Kajsa M Paulsson serves as Principal Investigator and Researcher at Lund University's Department of Experimental Medical Science within the Faculty of Medicine. She leads the Antigen Presentation research group at LUCC (Lund University Cancer Centre) and directs the Microscopy Community Lund University. Her strategic leadership extends to critical roles including project manager of Hanseatic League of Science (HALOS), board member of Lund Institute of Advanced X-ray and Neutron Sciences (LINXS), and regional coordinator for EATRIS-ERIC. Her research spans antigen presentation mechanisms across multiple disease contexts, with core projects investigating: tapasin as a prognostic tool in glioblastoma, immune responses to avian flu across species, and MHC-I molecules in ankylosing spondylitis. Methodologically, her work integrates molecular biology, cellular assays, tissue analysis, recombinant proteins, biochemistry, spectroscopy and scattering techniques. The research directly contributes to UN Sustainable Development Goals through life science infrastructure development. Analysis of her publication record reveals consistent focus on MHC class I antigen presentation , particularly tapasin-mediated quality control mechanisms across cancer (glioblastoma), infectious diseases (avian influenza), and autoimmune disorders (ankylosing spondylitis). Her work demonstrates strong interdisciplinary collaboration with 39 research outputs including 23 articles, 5 book chapters, and conference materials. Project manager Hanseatic League of Science (HALOS) (2019) Regional coordinator of EATRIS-ERIC (2018) Chair of Faculty of Medicine 'Active cooperation' action group (2020) Lund University EUGLOH-infra application coordinator (2020) Member of expert council for MAX IV/ESS strategy (2019) As an active supervisor, she has guided PhD students, master's students, and postdocs while managing 12 concurrent projects including HALRIC (2023-2026) and CIPA (2020-2027). Her infrastructure leadership includes InfraVis (national data visualization), Molecular Recognition in Life, and Microscopy Community Lund University, with work referenced in 5 Wikipedia pages and 1 patent.

Zahra Karimiمشاهده پروفایل

پژوهشگر

• Bioinformatics
• Food Science
• Molecular Biology
• +۳ مورد دیگر

Zahra Karimi is a Researcher at Cranfield University , affiliated with the Centre for Soil, Agrifood and Biosciences . She is part of the FoodBioSystems Doctoral Training Partnership funded by BBSRC and collaborates with Queen's University Belfast . Education: BSc in Biology MSc in Genetics and Bioinformatics PhD candidate in Food Authenticity via DNA barcoding Research Interests focus on Bioinformatics , Food Science , and Molecular Biology . Her work combines DNA barcoding , metabarcoding , and bioinformatic analysis to address food fraud and cross-contamination issues. Recent Articles demonstrate expertise in food authentication technologies (2025), honey adulteration detection (2025), and structural modeling of toxins (2012). Her publications span Food Science , Computational Biology , and Bioinformatics . Technical Expertise includes OMICs analysis Molecular techniques qPCR and DNA extraction from complex matrices Protein structure modeling Scientific software development

Edoardo Sozziمشاهده پروفایل

پژوهشگر ارشد

• Neuroscience
• Neurobiology
• Stem Cell Research
• +۶ مورد دیگر

Edoardo Sozzi is a Visiting Research Fellow and PhD student at Lund University's Faculty of Medicine, specializing in the Developmental and Regenerative Neurobiology group under Prof. Malin Parmar. He earned a BSc in Biotechnology (2018) and a dual MSc in Neuroscience (2020) from the University of Pisa and Scuola Normale Superiore, Italy. His research focuses on the development, functionality, and diversity of human dopaminergic neurons using 3D cell culture systems like brain organoids and xenograft models, with heavy reliance on single-cell RNA sequencing. His work intersects neuroscience, developmental biology, and regenerative medicine, targeting neurodegenerative disorders such as Parkinson's disease. Key publication trends include innovations in organoid technology , single-cell transcriptomics , and WNT signaling modulation . He has contributed to 11 scientific outputs , including a 2025 doctoral thesis, peer-reviewed articles in Nature Methods and Development , and a 2023 Horizon Europe grant (OpenMIND project) for opto-electronic neural modeling in neurodegenerative diseases. Sozzi actively participates in academic events, organizing conferences like Neuroscience Day 2024 and UniStem Day 2024 , and serves as a presenter in multidisciplinary initiatives (MultiPark). His work aligns with UN Sustainable Development Goals for Medical and Health Sciences and Neurosciences .

Sylvie Friantمشاهده پروفایل

پژوهشگر

• Membrane Trafficking
• Lipid Signaling
• Yeast Model Organism
• +۴ مورد دیگر

Sylvie Friant is a Senior Researcher (DR2) at the CNRS , leading the "Membrane Trafficking and Lipid Signaling" team at the University of Strasbourg's Department of Molecular and Cellular Biology since 2006. Her research explores the intersection of cell biology , lipid signaling , and human disease modeling using yeast ( Saccharomyces cerevisiae ) as a eukaryotic model organism. Education 2006: Habilitation to Direct Research (HDR), University of Strasbourg 1997: PhD in Molecular and Cellular Biology, University Louis Pasteur 1994: Master in Molecular and Cellular Biology, University of Strasbourg 1992: Bachelor in Biochemistry, University of Strasbourg Her work focuses on membrane trafficking , phosphoinositide signaling , and yeast-based human disease models , particularly for ciliopathies and neuromuscular disorders . Recent studies investigate PYROXD1 mutations in limb-girdle muscular dystrophy, VPS15/PIK3R4's role in retinitis pigmentosa, and MTMR2/MTM1 interactions in myopathies. Scientific contributions include CNRS Bronze Medal (2005) CNRS ATIP Starting Grant (2005) AcademiaNet nominee (2016) She has directed multiple PhD projects (e.g., Matthieu Raess) and secured grants from AFM-Téléthon, IdEx, and national institutions. Her team moved to the Strasbourg Biomedical Research Center (CRBS) in 2025.

Amparo Acker-Palmerمشاهده پروفایل

استاد

• Neuroscience
• Vascular Biology
• Cell-Cell Communication
• +۵ مورد دیگر

Amparo Acker-Palmer is a Professor at the Institute of Cell Biology and Neuroscience, part of the Cluster of Excellence Macromolecular Complexes (CEF) at Goethe University Frankfurt in Germany. Her laboratory investigates molecular mechanisms of cell-cell communication through ephrin/Eph receptor systems in neuronal and vascular networks. Research Focus Her group studies: Crosstalk between angiogenic/neurotrophic factors and ephrin signaling Molecular pathways in spine morphogenesis, synaptic plasticity, and dendritogenesis Ephrin-mediated neuronal migration during cortical development and adult neurogenesis Neuro-vascular interactions in development and disease contexts Methodologies Tandem Affinity Purification (TAP) proteomics in mammalian systems Primary neuronal/endothelial cell cultures (rat/mouse) Transgenic mouse models and time-lapse imaging Biochemical assays (kinase/IP/IF) and migration/adhesion analyses Her publications demonstrate consistent focus on Eph/ephrin signaling in neurodevelopment, plasticity, and angiogenesis across high-impact journals including Nature, Science, and Cell Reports.

Jeannette Nilsenمشاهده پروفایل

پژوهشگر ارشد

• Biochemistry
• Pharmacology
• Biomedical Engineering
• +۳ مورد دیگر

Jeannette Nilsen is a Postdoctoral Fellow at the Department of Pharmacology, University of Oslo (UiO). Her research focuses on protein engineering, pharmacology, and biomedical applications, particularly involving albumin and the neonatal Fc receptor (FcRn) interactions. Current Position: Postdoctoral Fellow Institution: University of Oslo Department: Pharmacology Email: jeannette.nilsen@medisin.uio.no Her work explores mechanisms of plasma half-life extension, mucosal drug delivery, and albumin-based therapeutics. Recent publications highlight collaborations with international researchers on FcRn-targeted nanosystems, engineered albumin fusions, and their applications in diabetes, hemophilia, and cancer treatments. Key trends in her research include pH-dependent albumin binding , transmucosal delivery , and optimizing biologics via FcRn affinity . All 15 articles emphasize interdisciplinary approaches bridging biochemistry, immunology, and pharmacology.

Lise Kvebergمشاهده پروفایل

پژوهشگر

• Immunology
• NK cell biology
• Cell therapy
• +۷ مورد دیگر

Lise Kveberg is a Researcher at the University of Oslo 's Center for Precision Immunotherapy (PRIMA) , Faculty of Medicine. Her work focuses on Immunology and Cell therapy , particularly NK cell biology and its clinical applications. Doctorate in Immunology (2005) Master of Science in Biology (1998) Her research explores NK cell receptors , immune checkpoints , and HLA interactions using rodent models. Key contributions include: 2024: Discovery of GPR56 as an inhibitory checkpoint for NK cell migration 2023: Characterization of KIR/HLA allelic variation in NK cell functional hierarchy 2022: Development of superdonor-derived NK cells for HLA-mismatched AML therapy Recent publications highlight her work in chemotaxis regulation , receptor-ligand dynamics , and transplant immunology . She collaborates with the Malmberg Group and previously coordinated the Center for Immune Regulation (2014-2018).

Chi Keung Lamمشاهده پروفایل

استادیار

• Cardiac Physiology
• Calcium Signaling in Cardiac Cells
• Cardiomyopathy Mechanisms
• +۵ مورد دیگر

Chi Keung Lam is an Assistant Professor in the Department of Biological Sciences at the University of Delaware . His research focuses on understanding mechanisms of cardiac diseases, particularly calcium signaling dysregulation and cardiotoxicity. He holds a B.S. from Purdue University, a Ph.D. from the University of Cincinnati, and completed postdoctoral training at Stanford University. Research Interests: Dr. Lam investigates heart disease mechanisms using human induced pluripotent stem cell (iPSC) models and mouse genetics. Key areas include calcium regulation in cardiac cells, drug-induced cardiotoxicity, and therapeutic development. Current projects explore novel regulators of calcium kinetics, cross-talk between calcium circuits and stress pathways, and mitigating cardiotoxic effects of cancer therapies. Key Contributions: His work integrates iPSC-derived cardiomyocytes with engineered heart tissues to test therapies. Notable achievements include identifying HAX-1's role in calcium signaling and developing peptide-based interventions for cardiac injury. The lab employs proteomic, genomic, and systems biology approaches to uncover disease mechanisms. Lab Team: Managed by Halley Wisner, the lab includes doctoral students Richard Roberts (Hsp90 in ischemic injury), Sujoita Sen (peptide therapy development), and Sophia Shienvold (Hsp90 post-translational modifications). Undergraduate researchers support ongoing projects. Research Trends: Recent publications emphasize drug discovery strategies, genetic cardiomyopathy modeling, and understanding cardiotoxic mechanisms of common medications. Work spans from molecular mechanisms to translational applications, bridging basic science and clinical needs.

• Microbial Food Safety
• Biosecurity
• Foodborne Pathogen Detection
• +۴ مورد دیگر

Dr. Maria Ma is a Professor in the Department of Entomology and Plant Pathology at Oklahoma State University (OSU), affiliated with the Institute of Biosecurity & Microbial Forensics. She holds an 80% research and 20% teaching appointment. Dr. Ma specializes in microbial food safety and biosecurity, focusing on foodborne pathogen detection, contamination route analysis, and decontamination technologies. Educated at Purdue University (Ph.D. in Food Microbiology) and Dalian Polytechnic University (B.S. in Fermentation Engineering), she has over 15 years of academic experience, including postdoctoral research at the University of Georgia and guest work at the CDC. Her research spans novel detection methods (e.g., LAMP assays, PCR), cold plasma decontamination systems, and biosecurity strategies. She teaches advanced courses like Microbial Forensics and Career Skills for Scientists. Dr. Ma has secured funding from agencies like USDA NIFA for projects addressing pecan orchard food safety, pathogen controls, and biosecurity training. Her lab mentors Ph.D. and M.S. students in applied microbiology and food safety innovation.

Paul Campagnolaمشاهده پروفایل

عضو هیئت علمی

• Biomedical Engineering
• Cell Biology
• Medical Imaging
• +۳ مورد دیگر

Paul Campagnola is an Affiliated Professor in the Department of Physics at the University of Wisconsin-Madison. His research focuses on advanced optical imaging techniques, particularly second harmonic generation (SHG) microscopy, to study collagen architecture alterations in diseases such as ovarian cancer, idiopathic pulmonary fibrosis, and lichen sclerosus. He specializes in developing biomimetic models and computational tools to analyze extracellular matrix dynamics and cell-matrix interactions. His work bridges physics, biomedical engineering, and oncology, emphasizing translational applications in diagnostics and therapeutics. Education: No explicit education details provided. Research Interests: Optical microscopy innovations for biomedical applications Collagen structure analysis in disease progression 3D tissue imaging and modeling Machine learning for image data interpretation Recent Research Trends: Recent articles emphasize SHG imaging applications in cancer pathology, fibrotic diseases, and biomaterials. Studies highlight collagen's role as both a structural and functional biomarker, with focus on computational modeling and multiscale imaging techniques. Grants & Advising: No grants or advisees explicitly listed. Active in interdisciplinary collaborations involving physics, engineering, and clinical medicine. Labs & Teams: Engaged in tissue engineering and biophotonics research groups, though specific lab affiliations are not detailed in provided text.

Eunsook Parkمشاهده پروفایل

استادیار

• Plant Immunity
• Organelle Dynamics
• Autophagy Modulation
• +۳ مورد دیگر

Dr. Eunsook Park is an Assistant Professor in the Department of Molecular Biology at the University of Wyoming, affiliated with the College of Agriculture, Life Sciences and Natural Resources. Her research focuses on understanding organelle dynamics and their roles in plant immunity, particularly chloroplast-nucleus communication during stress responses and autophagy modulation in fungal pathogens. She investigates how pathogens disrupt host organelle function and employs high-throughput screening to develop novel antifungal agents. Her research interests are divided into two main areas: 1) Exploring chloroplast-nucleus communication mechanisms during plant immune responses to microbial infections, and 2) Developing autophagy-modulating compounds to combat fungal diseases. Recent work includes studies on RXLR effector proteins disrupting vesicle trafficking and BRET-based screens for antifungal lead compounds. Key achievements include establishing a non-integrative viral delivery system for CRISPR-Cas9 genome editing in plants and characterizing the role of NLR immune receptors in programmed cell death. Her work is supported by grants such as an international NIH-funded project in Korea. While no formal advisees are listed, her lab focuses on plant-microbe interactions, organelle biology, and translational research for agricultural applications. No scientific awards are explicitly mentioned in the provided texts.

• Neurodegenerative Diseases
• Parkinson's Disease
• Clinical Neuroscience
• +۴ مورد دیگر

Professor George Mellick is a faculty member at Griffith University, affiliated with the School of Environment and Science and the Department of Bioscience. He holds the rank of Professor and leads research in neurodegenerative diseases, particularly Parkinson’s. His roles include Head of School (2018–2022) and Deputy Director of the Griffith Institute for Drug Discovery (2013–2018). He is currently a member of the Institute for Biomedicine and Glycomics. Education & Research Interests Mellick’s research focuses on Parkinson’s disease mechanisms, genetics, and therapeutic interventions. He has extensive experience in drug discovery, natural product screening, and molecular biology. His work integrates clinical, genetic, and biochemical approaches to understand disease progression. Grants & Collaborations He has led multiple grants, including studies on Kir4.2 channel mechanisms ($176,460 MJFF grant), mitochondrial modulators, and Parkinson’s genetics. Collaborations include institutions like the Clem Jones Centre for Neurobiology and the Michael J. Fox Foundation. Awards & Advocacy A recipient of the National Teaching Award, Mellick is also Chair of Parkinson’s Australia, advocating for the Parkinson’s community. He retired from Parkinson’s Queensland after 22 years, serving as President for 9 years. Labs & Teams Affiliated with the Griffith Institute for Drug Discovery and the Institute for Biomedicine and Glycomics, he leads interdisciplinary teams exploring Parkinson’s pathogenesis and drug development.

Bilal Zulfiqarمشاهده پروفایل

پژوهشگر ارشد

• Drug Discovery
• High-Throughput Screening
• High-Content Imaging
• +۳ مورد دیگر

Bilal Zulfiqar is a Postdoctoral Research Fellow in Discovery Biology at Griffith University's School of Environment and Science. He specializes in drug discovery for neglected tropical diseases, particularly leishmaniasis and Chagas disease, leveraging high-content imaging and high-throughput screening techniques. His work focuses on developing multiplexed assays for cytological and phenotypic profiling of novel therapeutics. Education: Pharm.D. (Doctor of Pharmacy), Hamdard University, Pakistan (2008) M.Phil. in Virology and Immunology, National University of Sciences and Technology (NUST), Pakistan (2011) Ph.D. in Pharmacology/Drug Discovery, Griffith University, Australia (2014–2018) Research Interests: Drug discovery for kinetoplastid infections, high-throughput screening methodologies, cancer immunotherapy, and the application of nanomedicine in biomedical research. His work bridges basic science and translational research, aiming to address unmet clinical needs in infectious and oncological diseases. Publications: Bilal has contributed to over 20 peer-reviewed articles, including seminal work on leishmaniasis drug discovery assays and preclinical candidates like DNDI-6174. His research highlights include the development of novel anti-Giardia compounds and the evaluation of amiodarone in Chagas disease contexts. Awards: 2020 Griffith Institute RICE Award for Excellence in Research 2017 SLAS Best Academic Poster Award (Washington, D.C.) Multiple travel grants supporting global research collaborations Advising & Grants: Currently serves as an associate supervisor for Griffith University doctoral and master’s projects focused on natural product-derived trypanocidal compounds. His research has been supported by DNDi collaborations and institutional grants. Labs/Teams: A core member of the Discovery Biology team at Griffith, collaborating with global networks like the Drugs for Neglected Diseases Initiative (DNDi) to advance drug pipelines for neglected diseases.